Fucoidan was reported previously to increase expression of both Nrf2 and HO-1 in chronic kidney disease in mice [37], cyclophosphamide-induced liver and kidney injury in mice [38], diabetes-induced renal fibrosis in vivo and in vitro [39] and LPS-induced acute lung injury in mice [40]. This evidence concerns the gene HMOX1 and chronic kidney disease.